COMPARISON OF REAL-WORLD SAFETY AND EFFECTIVENESS OF MEPOLIZUMAB AND BENRALIZUMAB IN THE MANAGEMENT OF SEVERE ASTHMA: A SYSTEMATIC REVIEW

被引：0
|
作者：
Bhavanasai, S. [1 ]
Vullengala, N. [1 ]
Yarramsetti, P. [1 ]
Jan, R. [1 ]
Kaur, G. [1 ]
Udhayasri, R. [1 ]
Sodhi, B. [1 ]
Gomes, A. [1 ]
Dang, A. [1 ]
Dang, D. [1 ]
Vallish, B. N. [1 ]
机构：
[1] MarksMan Healthcare Commun, Hyderabad, Telangana, India
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD100
引用
收藏
页码：S523 / S523
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of Mepolizumab in a real world severe asthma cohort
    Mitchell, Verity
    Howles, Katie
    White, Lisa
    Pillai, Anilkumar
    Mansur, Adel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [32] A real-life comparison of patients with severe eosinophilic asthma treated with benralizumab or mepolizumab
    Andersen, Helle H.
    Smidt-Hansen, Torben
    Pedersen, Lene M.
    Skjold, Tina
    Schmid, Johannes
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [33] COMPARISON OF BENRALIZUMAB AND MEPOLIZUMAB OUTCOMES IN TWO SEVERE ASTHMA CLINICS
    Khung, S.
    Politis, J.
    Adriana, A.
    Ruane, L.
    Sharp, J.
    Bardin, P.
    Langton, D.
    RESPIROLOGY, 2021, 26 : 42 - 42
  • [34] Comparison of benralizumab and mepolizumab outcomes in two severe asthma clinics
    Politis, J.
    Khung, S.
    Collyer, T.
    Avram, A.
    Ruane, L.
    Sharp, J.
    Bardin, P.
    Langton, D.
    RESPIROLOGY, 2022, 27 : 33 - 33
  • [35] Real-world treatment patterns of benralizumab therapy for patients with severe asthma
    Gendron, Alain
    Sriskandarajah, Niroshan
    Johnston, Karissa
    Osenenko, Kathy M.
    Noorduyn, Stephen G.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [36] Real-World Clinical Outcomes of Asthma patients switched from Reslizumab to either Mepolizumab or Benralizumab
    Walsh, Laura J.
    Casey, Deborah
    Vairamani, Punitha
    Arnott, Fiona
    Plant, Barry J.
    Murphy, Desmond M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 : S138 - S138
  • [37] The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma
    Hearn, Andrew P.
    Kavanagh, Joanne
    d'Ancona, Grainne
    Roxas, Cris
    Green, Linda
    Thomson, Louise
    Fernandes, Marianna
    Kent, Brian D.
    Dhariwal, Jaideep
    Nanzer, Alexanda M.
    Jackson, David J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (05): : 2093 - +
  • [38] Real-world effectiveness of mepolizumab in patients with asthma and comorbid nasal polyps
    Ou, Ming-Che
    Tsai, Ru-Yin
    Li, Chen-Pi
    Gau, Shuo-Yan
    Chang, Hui-Chin
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06)
  • [39] Benralizumab effectiveness in patients with severe asthma regardless of prior biologic use: A real-world Canadian experience
    Nair, Parameswaran
    Kayaniyil, Sheena
    St Pierre, Charles
    Osenenko, Katherine
    Li, Tina
    Johnston, Karissa
    Lacuesta, Gina
    Khan, Irfan
    Anees, Syed
    Lai, Yew Hon
    Rahimi, Parisa
    Dhawan, Vivek
    Dorscheid, Delbert
    Cote, Andreanne
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [40] Super-responder analysis and real-world one year effectiveness of benralizumab in severe eosinophilic asthma
    Kavanagh, Joanne
    Roxas, Cris
    Green, Linda
    Fernandes, Mariana
    Thomson, Louise
    Payne, Victoria
    Hearn, Andrew
    Kent, Brian D.
    D'Ancona, Grainne
    Dhariwal, Jaideep
    Nanzer, Alexandra M. A.
    Jackson, David J.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
12345